Common Medications That Impair Heat Tolerance
Several medication classes significantly impair thermoregulation during hot weather, with anticholinergics, antipsychotics, non-selective beta-blockers, and diuretics (especially when combined with ACE inhibitors or ARBs) posing the greatest risk.
Medications with Strong Evidence for Heat Intolerance
High-Risk Medications
Anticholinergics are the most problematic class, increasing core temperature by approximately 0.42°C during heat exposure at temperatures ≥30°C while simultaneously reducing sweating capacity 1. This dual mechanism—blocking sweat production while raising core temperature—creates dangerous conditions during heat waves. The evidence is strongest for atropine, but this applies broadly to drugs with high anticholinergic properties 1.
Antipsychotics carry substantial risk, with a 4.6-fold increased odds of heat-related hospitalization during heat waves 2. These medications impair central thermoregulation and often have anticholinergic side effects that compound the problem 3.
Non-selective beta-blockers elevate core temperature by 0.11°C during heat stress 1. They reduce cardiac output and limit the cardiovascular system's ability to increase skin blood flow for heat dissipation, while also potentially reducing sweat production 4.
Diuretics, particularly when combined with ACE inhibitors or ARBs, create a "perfect storm" by causing volume depletion and electrolyte imbalances that compromise both cardiovascular compensation and thermoregulation 3. This combination is especially dangerous because it's commonly prescribed to elderly patients who already have reduced thermoregulatory capacity.
Moderate-Risk Medications
Anti-Parkinson's agents increase core temperature by 0.13°C during heat exposure 1. These medications often have anticholinergic properties and can impair both central temperature regulation and peripheral heat loss mechanisms.
Anxiolytics show a 2.4-fold increased odds of heat-related hospitalization 2. They cause sedation and cognitive impairment that reduces heat-protective behaviors and awareness of heat stress symptoms 3.
Adrenaline raises core temperature by 0.41°C during heat stress 1, though this is less relevant for chronic medication use.
Medications WITHOUT Strong Evidence for Heat Risk
Antidepressants did not show significant alterations in core temperature responses during heat stress in the meta-analysis 1, despite being frequently listed on heat-warning medication lists. This represents an important gap between public health warnings and actual evidence.
Drugs with weak anticholinergic effects also did not demonstrate impaired thermoregulation 1.
Critical Clinical Considerations
The Evidence Gap
The current evidence base has major limitations that affect real-world applicability 1:
- Studies predominantly involve healthy young men (only 4.5% women in the meta-analysis)
- Average participant age across studies was <30 years
- Only one study included patients with actual chronic diseases
- Heat exposures were short-duration laboratory studies, not prolonged real-world heat waves
This means the risk in elderly patients with multiple chronic conditions—the actual at-risk population—is likely underestimated.
Timing of Risk
Heat-sensitizing medications increase hospitalization risk throughout summer months, not just during heat waves 5. The rate ratios ranged from 1.16 to 1.37 even without heat wave conditions. This means medication reviews should occur before summer begins, not just when heat waves are forecasted 3.
Synergistic Effects
While individual medications increase risk, there was no meaningful synergistic interaction between heat waves and medications in the statistical sense 5. However, the combination of multiple heat-sensitizing medications in polypharmacy patients creates cumulative physiologic burden through different mechanisms 3, 4.
Mechanistic Pathways to Understand
These medications impair heat tolerance through five main mechanisms 3:
- Reduced sweating (anticholinergics, antipsychotics)
- Impaired cardiovascular compensation (beta-blockers, diuretics)
- Volume depletion and electrolyte imbalance (diuretics)
- Sedation and reduced heat-protective behaviors (anxiolytics, antipsychotics)
- Direct effects on central thermoregulation (antipsychotics, anti-Parkinson's agents)
Common Pitfalls
Do not assume all medications on WHO warning lists have equal evidence. The 2024 systematic review found that many commonly cited medications lack supporting data for thermoregulatory impairment 1.
Do not wait for heat waves to review medications. Risk is elevated throughout hot weather, and medication adjustments take time to implement safely 3, 5.
Do not assume young, healthy patients are representative of your elderly, chronically ill patients. The evidence base is severely limited for the actual at-risk population 1.